Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), sold 70,000 shares at $4.07 ($284K) on 2021-01-11, disclosed to the SEC on 2021-01-13.
Open-market sale of $284k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.05 | 50,000 | $203K | 71.3% |
| 2 | $4.07 | 20,000 | $81K | 28.7% |
| Total | $4.06 avg | 70,000 | $284K | 100% |
| Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |
| ATRS | SELL | 2017-10-05 | $105K | — | Filing → |